1st Edition of EHS Task Force Public Debate


The first edition of EHS Task Force Public Debate on “Pandemics and Vaccines, Hera Incubator” gathered 7 experts from the health sector and attracted over 200 viewers. 


We extend our special thanks to our speakers and viewers and wish to meet again at the European Health Summit on 9 December 2021.  



Pierre Delsaux, Deputy Director General, DG SANTÉ, European Commission: “With funds from the European Commission, the HERA Incubator has created a clinal trial network in the EU to speed up the authorisation process for a new variant vaccine.” / “HERA will focuse on COVID but also on future pandemics by monitoring the situation, anticipating the issue and providing the necessary measures.”

Maria Carvalho, Member of the European Parliament: “We need more investment in the health ecosystem to be able to transform the knowledge in solutions in a short time and in an effective & affordable way. We need to reduce the bureaucracy & the market fragmentation.”

Luc Debruyne, Strategy Advisor to CEO, CEPI & Former CEO, GSK Vaccines: “2021 is a complex year because it is all about the virus behaviour and its effect on the vaccination strategies. We are turning to a regional approach. CEPI will be an enabler to make sure we deal with this pandemic in a global and collaborative way.”

Heike Galbraith, Pfizer, Global Director rare diseases and vaccines: “I can only support the use of artificial intelligence & IT in improving clinical trials. The protection of Intellectual Property rights plays a big role, we wouldn’t have had the vaccines so quickly without it.” / “The power of collaboration is a key learning from this pandemic.”

Sam Proesmans, Advisor to the Belgian Prime Minister: “As Member States we should have some self-reflection: What are we best at and how we can contribute to HERA?” / “We need to coordinate across borders on the healthcare response. A better coordination on all levels will be beneficial to all member states.”

Elena Bonfiglioli, Microsoft, Regional business leader health and life sciences EMEA: “We need to make sure to invest in the resilience of the health system. We need to build something that will equip our response better and faster as we go forward.” / “We need to continue thinking on transparency for vaccine planning, to give clarity of what’s happening, and to provide a real time response to the citizens’ demands. We need to share sequencing data at European level.”

For more information, contact Felicia Balan, Project Manager

felicia@ebsummit.eu / +32 (0)2 645 3 484